Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_assertion type Assertion NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_head.
- NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_assertion description "[The relationship between high ZEB2 or low CDH1 expression and shorter progression-free survival was validated by real-time RT-PCR experiments of 37 independent advanced stage cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_provenance.
- NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_assertion evidence source_evidence_literature NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_provenance.
- NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_assertion SIO_000772 19486012 NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_provenance.
- NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_assertion wasDerivedFrom befree-20140225 NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_provenance.
- NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_assertion wasGeneratedBy ECO_0000203 NP581547.RA68_oYTn2B6N4YTc6zotBYu6-3nY7ky1dBuefP7Tv5qc130_provenance.